Article
Outcomes favorable in 2-year experience with silicone IOL
San Diego - Two-year follow-up of eyes with the ClariFlex with OptiEdge silicone IOL (AMO) implanted show that the second-generation silicone IOL with its novel edge design is performing well. Furthermore, risk of posterior capsular opacification (PCO) and glare was minimal, according to the results of a study presented by Elizabeth A. Davis, MD, FACS, at the annual meeting of the American Society of Cataract and Refractive Surgery.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
